Search results for : aurka - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Search Results for: aurka

Drugs (10)

Name	Synonyms	Targets	Target Pathway	PubCHEM	Datatset	Sample size	Screening site
Alisertib	MLN8237	AURKA	Mitosis		GDSC1	891	MGH
Alisertib	MLN8237	AURKA	Mitosis	24771867	GDSC2	949	SANGER
CD532		AURKA	Mitosis		GDSC1	920	MGH
GSK1070916	GSK-1070916	AURKA, AURKC	Mitosis	46885626	GDSC1	868	MGH
Genentech Cpd 10		AURKA, AURKB	Mitosis	none	GDSC1	912	MGH
HG-5-113-01		AURKA	Mitosis	none	GDSC1	491	SANGER
Tozasertib	MK 0457,MK-0457,MK-045, VX-680 VX 680 VX-68	AURKA, AURKB, AURKC, others	Mitosis	5494449	GDSC1	392	MGH
Tozasertib	MK 0457,MK-0457,MK-045, VX-680 VX 680 VX-68	AURKA, AURKB, AURKC, others	Mitosis	5494449	GDSC2	268	SANGER
ZM447439	ZM-447439, ZM 447439	AURKA, AURKB	Mitosis	9914412	GDSC1	933	SANGER
ZM447439	ZM-447439, ZM 447439	AURKA, AURKB	Mitosis	9914412	GDSC2	944	SANGER

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).